what is the performance mid cap stock between march 13 2017 and june 30 2017

Catalyst Pharmaceuticals (CPRX) had the highest return between March 13, 2017 and June 30, 2017 by a mid-cap US stock, returning 146.4%.

ASSET DATE % RETURN
Catalyst Pharmaceuticals (CPRX)
3/13/2017 - 6/30/2017
146.43%
Wayfair (W)
3/13/2017 - 6/30/2017
111.27%
Immunitybio (IBRX)
3/13/2017 - 6/30/2017
87.41%
Floor & Decor (FND)
3/13/2017 - 6/30/2017
86.95%
RH (RH)
3/13/2017 - 6/30/2017
84.13%
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX)
3/13/2017 - 6/30/2017
80.9%
PTC Therapeutics (PTCT)
3/13/2017 - 6/30/2017
74.9%
Impinj (PI)
3/13/2017 - 6/30/2017
74.25%
EXACT Sciences (EXAS)
3/13/2017 - 6/30/2017
65.51%
Supernus Pharmaceuticals (SUPN)
3/13/2017 - 6/30/2017
64.19%
HUTCHMED DRC (HCM)
3/13/2017 - 6/30/2017
60.76%
Bancorp (TBBK)
3/13/2017 - 6/30/2017
54.38%
Etsy (ETSY)
3/13/2017 - 6/30/2017
54%
Appian (APPN)
3/13/2017 - 6/30/2017
51.25%
Molina Healthcare (MOH)
3/13/2017 - 6/30/2017
51.21%
Freshpet (FRPT)
3/13/2017 - 6/30/2017
50.91%
RadNet (RDNT)
3/13/2017 - 6/30/2017
47.62%
BRP (DOOO)
3/13/2017 - 6/30/2017
47.55%
Penn National Gaming (PENN)
3/13/2017 - 6/30/2017
46.92%
Globalstar, Inc Common Stock (GSAT)
3/13/2017 - 6/30/2017
46.9%
BlackBerry (BB)
3/13/2017 - 6/30/2017
45.84%
Modine Manufacturing (MOD)
3/13/2017 - 6/30/2017
45.18%
Axcelis Technologies (ACLS)
3/13/2017 - 6/30/2017
42.52%
Sunrun (RUN)
3/13/2017 - 6/30/2017
40.71%
IAMGold (IAG)
3/13/2017 - 6/30/2017
40.6%
Mid-cap stocks are treated as having a market cap between $2B and $10B.